Ein Arzt berät einen Patienten (Symbolbild).
Montag, 13.06.2016 16:05 von | Aufrufe: 73

International Isotopes Inc. Announces The U.S. Nuclear Regulatory Commission Has Concluded Its Investigation Of The Company's August 2015 Radiation Exposure Event And Determined No Civil Penalty Will

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

IDAHO FALLS, Idaho, June 13, 2016 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") has announced that the U.S. Nuclear Regulatory Commission (NRC) has completed its investigation and issued a Special Inspection Report of the August 2015 exposure event that occurred at the Company's facility in Idaho Falls. 

The Company took the opportunity to discuss the apparent violations identified by the NRC at a Pre-Enforcement Conference with the NRC on May 3, 2016.  During that conference the Company provided a detailed description of the corrective actions taken to address and prevent reoccurrence of the exposure event.

Based upon the information gathered by the NRC during their inspection and the information provided by the Company, the NRC determined that four violations of NRC requirements occurred.  However, because of the prompt and comprehensive corrective actions taken by the Company and because no previous enforcement action has been taken against International Isotopes Inc. the NRC determined that it will not impose any civil penalty in this case.  The NRC also determined that all of the information provided by the Company with regard to its investigation of the event, the root cause analysis performed, and the corrective action plan that was initiated, were all complete and no additional information will be required by the NRC. 

Steve T. Laflin, President and CEO of the Company commented, "We are glad to have this process completed and while the exposure incident was certainly unfortunate, we believe we have taken all appropriate steps to prevent recurrence and to make long-lasting improvements in the quality of our safety and design control processes." 

About International Isotopes Inc.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, a variety of cobalt-60 products, provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, and industrial applications, and provides radiological services including source installation/removal, and decommissioning various radiation units on a contract basis to clients.

International Isotopes Inc. Safe Harbor Statement
Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the trends in company performance.  Information contained in such forward-looking statements is based on current expectations and is subject to change.  These forward looking statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in the Company's filings with the Securities and Exchange Commission at www.sec.gov, including our Annual Report on Form 10-K for the year ended December 31, 2015.  Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

FOR MORE INFORMATION CONTACT:
David Drewitz
Creative Options Communications
Investor and Public Relations
david@creativeoptionscommunications.com
www.creativeoptionsmarketing.com
Phone:  972-814-5723


ARIVA.DE Börsen-Geflüster

Kurse

0,03855 $
+1,45%
International Isotopes Chart
Werbung

Mehr Nachrichten zur International Isotopes Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News

PR Newswire Thumbnail
25.04.24 - PR Newswire